The expression level of NF-κB p65 increased, and the TNF-α content of NF-κB downstream inflammatory factor was elevated, suggesting that the activation of the TLR4/NF-κB signaling pathway might be involved in the pathogenesis of MS. The gene discussed is NFKB1; the disease is myeloid sarcoma.